Author Correction: Binding of the protein ICln to α-integrin contributes to the activation of ICl

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 Nov 2019
Historique:
entrez: 16 11 2019
pubmed: 16 11 2019
medline: 16 11 2019
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-019-53690-5 PMID: 31728022 PMC: PMC6856531
pubmed: 31728022
doi: 10.1038/s41598-019-53690-5
pii: 10.1038/s41598-019-53690-5
pmc: PMC6856531
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

17107

Commentaires et corrections

Type : ErratumFor

Auteurs

Andreas Schedlbauer (A)

Department of Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, 1030, Vienna, Austria.
Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE), Bizkaia Science and Technology Park, 48160, Derio (Bizkaia), Spain.

Grazia Tamma (G)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, 70126, Bari, Italy.
Istituto Nazionale di Biostrutture e Biosistemi, 00136, Rome, Italy.

Simona Rodighiero (S)

Department of Experimental Oncology, European Institute of Oncology, 20141, Milan, Italy.

Davide Antonio Civello (DA)

Institute of Pharmacology and Toxicology, Paracelsus Medical University, 5020, Salzburg, Austria.

Margherita Tamplenizza (M)

Tensive S.r.l., 20139, Milan, Italy.

Karin Ledolter (K)

Department of Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, 1030, Vienna, Austria.

Charity Nofziger (C)

PharmGenetix Gmbh, 5081, Niederalm, Austria.

Wolfgang Patsch (W)

Institute of Pharmacology and Toxicology, Paracelsus Medical University, 5020, Salzburg, Austria.

Robert Konrat (R)

Department of Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, 1030, Vienna, Austria.

Markus Paulmichl (M)

Department of Personalized Medicine, Humanomed, 9020, Klagenfurt, Austria.

Silvia Dossena (S)

Institute of Pharmacology and Toxicology, Paracelsus Medical University, 5020, Salzburg, Austria. silvia.dossena@pmu.ac.at.
ORCID: 0000-0002-6694-9249

Classifications MeSH